跳至主要内容
临床试验/NL-OMON34626
NL-OMON34626已完成不适用

Is the Level of Skin Autofluorescence (SAF) Related to Complications in Pregnant Patients with Diabetes Mellitus? - Skin Autofluorescence in Pregnant Patients with Diabetes Mellitus

Academisch Medisch Centrum0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Pregnant patients with diabetes (GDM or pre-existent diabetes mellitus) or patients with one abnormal value at OGTT
  • -Written informed consent
  • -Knowledge of Dutch

排除标准

  • -renal failure (GFR < 30 ml/min)
  • -Negroid skin type
  • -skin reflectance < 6% (the AGE-reader will automatically give an alarm when reflection is too low for the measurement to be reliable, these patients will be excluded)
  • -pre-eclampsia at inclusion
  • -Recent (< 6 months) serious infection or infarction or hospital admission/ or clinical condition judged by the investigator as interfering with skin autofluorescence measurement

研究者

相似试验